Right to Try Act. Whereas the process of approval for life-saving treatments to terminally ill patients in Canada often takes many years;

Similar documents
SASKATCHEWAN ASSOCIATIO. Guideline for RN(NP) Involvement in Medical Assistance in Dying

SASKATCHEWAN ASSOCIATIO. Guideline for RN Involvement in Medical Assistance in Dying

Medical Aid in Dying (MAID) Update July 14, 2016

Professional Standard Regarding Medical Assistance in Dying

The Pharmacy and Pharmacy Disciplines Act SASKATCHEWAN COLLEGE OF PHARMACY PROFESSIONALS REGULATORY BYLAWS

STATE OF RHODE ISLAND

49 USC NB: This unofficial compilation of the U.S. Code is current as of Jan. 4, 2012 (see

DECEMBER 6, 2016 MEDICAL ASSISTANCE IN DYING GUIDANCE FOR PHARMACISTS AND PHARMACY TECHNICIANS

Terms and Conditions. Growing Assurance - Ecological Goods and Services. Definitions. Program Description

SENATE, No. 801 STATE OF NEW JERSEY. 216th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2014 SESSION

Prescriptive Authority for Pharmacists. Frequently Asked Questions for Pharmacists

NURSE PRACTITIONERS PROVIDING MEDICAL ASSISTANCE IN DYING (MAID)

Medical Assistance in Dying

ADVANCE DIRECTIVE FOR A NATURAL DEATH ("LIVING WILL")

H 7297 S T A T E O F R H O D E I S L A N D

REGISTERED NURSES ACT

The Registered Nurses Act, 1988

Senate Bill No. 453 Committee on Health and Human Services

SENATE, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED APRIL 28, 2014

TENNESSEE CODE ANNOTATED 2008 by The State of Tennessee Title 49 Education Chapter 5 Personnel Part 4 --Employment and Assignment of Personnel

Province of Alberta ALBERTA HEALTH ACT. Statutes of Alberta, 2010 Chapter A Current as of January 1, Published by Alberta Queen s Printer

Medical Assistance in Dying

AN ACT. Be it enacted by the General Assembly of the State of Ohio:

Medical Assistance in Dying (Practitioner Administered) Practice Guideline for Pharmacists and Pharmacy Technicians

24 (b) "Boards" means the Board of Medicine and the Board. 27 graduated from an approved program, who is licensed to perform

College of Physicians and Surgeons of Newfoundland & Labrador STANDARD OF PRACTICE

Healthcare Professions Registration and Standards Act 2007

Senate Bill 1547 Ordered by the Senate February 15 Including Senate Amendments dated February 15

ENLISTMENT ACT (CHAPTER 93)

Medical Assistance in Dying

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

Volume 22, Number 1, Fall Medical Assistance in Dying Frequently Asked Questions

DRAFT FOR INFORMAL COMMENT

CATHOLIC CAMPAIGN FOR HUMAN DEVELOPMENT GRANT AGREEMENT

NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT

Province of Alberta HOSPITALS ACT. Revised Statutes of Alberta 2000 Chapter H-12. Current as of December 9, Office Consolidation

Senate File Introduced

PROPOSED REGULATION - FOR CONSULTATION. Pharmacy Act, 1991 Loi de 1991 sur les pharmaciens ONTARIO REGULATION 202/94 GENERAL DRAFT

NORTH CAROLINA Advance Directive Planning for Important Health Care Decisions

NATIONAL HEALTH BILL 2008 (SB.50)

HEALTH CARE PROVIDERS IMMUNITY FROM LIABILITY ACT

PPG Medical Assistance in Dying (MAiD)

Proposed amendments to the Marihuana for Medical Purposes Regulations

Referred to Committee on Health and Human Services. SUMMARY Provides for schools to obtain and administer autoinjectable epinephrine.

Chapter 52. Board of Pharmacy.

COMMUNITY CARE FACILITIES AND NURSING HOMES ACT

P.L.2012, CHAPTER 6, approved May 2, 2012 Senate, No. 852

An Act respecting end-of-life care

ATTORNEY COUNTY OF. Page 1 of 5

Overview of. Health Professions Act Nurses (Registered) and Nurse Practitioners Regulation CRNBC Bylaws

A BILL FOR. Incidental Matters

PHARMACITS COUNCIL OF NIGERIA ACT (1992 No. 91) REGISTRATION OF PHARMACEUTICAL PREMISES REGULATIONS, 2005.

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. Senate Bill 1547

As Introduced. 131st General Assembly Regular Session H. B. No

I. Mission Statement and Activities of the Board 2. Massachusetts General Laws Governing Nursing Practice and Education 3-18

CHAPTER MEDICAL IMAGING AND RADIATION THERAPY

REQUEST FOR SELF-ADMINSTRATION OF MEDICATION AT SCHOOL (Only for Epi-Pen and Metered Dose Inhaler) School: Teacher: Grade:

1 SB By Senator Whatley. 4 RFD: Education and Youth Affairs. 5 First Read: 01-FEB-18. Page 0

HOSPITALS AND HEALTH CARE FACILITIES ARRANGEMENT OF SECTIONS

STUDENTS 3416 page 1 of 4 Administering Medicines to Students

An Act furthering health empowerment and affordability by leveraging transformative health care.

BE IT ENACTED by the National Assembly of the Federal Republic of Nigeria as follows:

ASSEMBLY HEALTH AND SENIOR SERVICES COMMITTEE STATEMENT TO. ASSEMBLY, No STATE OF NEW JERSEY DATED: JUNE 13, 2011

1. A. Prescription medication must be in an original container/vial issued by a pharmacy that indicates the following information:

1. Citation and commencement 2. Definitions 3. Application

Child Care Benefit (Eligibility of Child Care Services for Approval and Continued Approval) Determination 2000

Alert. Changes to Licensed Scope of Practice of Physician s Assistants in Michigan. msms.org. Participating Physician. Practice Agreement

Unlicensed Medicines Policy

Medical Assistance in Dying Presentation #1 July 12, 2016

REGULATION MARKUP REGULATION NO. 2

DISCIPLINE COMMITTEE OF THE COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO. - and -

SENATE, No. 380 STATE OF NEW JERSEY. 210th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2002 SESSION

HEALTH CARE POWER OF ATTORNEY

MEMO. Date: 29 March 2016 To: All NH Physicians From: Kirsten Thomson, Regional Director, Risk & Compliance Re: Medical Assistance in Dying

Deadline: Thursday, March 29, Applicant Business Information. Application 2018 Outside Mural and Street Art Grant

Policy Title: Administration of Medication by School Personnel Policy No:

ENROLLMENT APPLICATION

NURSES ACT CHAPTER 257 CAP Nurses LAWS OF KENYA

Medical Marijuana - Act 16 of 2016

Senate Bill No. 294 Senators Cegavske and Leslie

BY-LAW #3 (Under Section 40(2) of The Medical Act)

PATIENT RIGHTS TO ACCESS PERSONAL MEDICAL RECORDS California Health & Safety Code Section

2017 Session (79th) A SB Senate Amendment to Senate Bill No. 291 (BDR ) Proposed by: Senate Committee on Commerce, Labor and Energy

AN ACT authorizing the provision of health care services through telemedicine and telehealth, and supplementing various parts of the statutory law.

A Bill Regular Session, 2017 HOUSE BILL 1628

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2015 HOUSE DRH20205-MG-112 (03/24) Short Title: Enact Death With Dignity Act. (Public)

Be it enacted by the People of the State of Illinois,

3. Practicing fraud, deceit, or misrepresentation in the practice of medicine.

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2011 H 1 HOUSE BILL 639. Short Title: Clinical Exercise Physiologist Licensure.

DECLARATIONS FOR MENTAL HEALTH TREATMENT

LOUISIANA REVISED STATUTE 37: THE LOUISIANA RADIOLOGIC TECHNOLOGIST LICENSING LAW

7.200 DONATION OF UNUSED MEDICATIONS, MEDICAL DEVICES AND MEDICAL SUPPLIES

ALABAMA~STATUTE. Code of Alabama et seq. DATE Enacted Alabama Board of Medical Examiners

ASSEMBLY, No STATE OF NEW JERSEY. 218th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2018 SESSION

CHAPTER Committee Substitute for Committee Substitute for House Bill No. 1411

SEC UNIFORM STANDARDS FOR THE INTERROGATION OF PERSONS UNDER THE DETENTION OF THE DEPARTMENT OF DEFENSE.

An Act to amend the Pharmacy Act

THIS AGREEMENT made effective this day of, 20. BETWEEN: NOVA SCOTIA HEALTH AUTHORITY ("NSHA") AND X. (Hereinafter referred to as the Agency )

Bill 59 (2012, chapter 23) An Act respecting the sharing of certain health information

UNIFORMED AND OVERSEAS CITIZENS ABSENTEE VOTING ACT (UOCAVA) (As modified by the National Defense Authorization Act for FY 2010)

Transcription:

Right to Try Act Preamble Whereas the process of approval for life-saving treatments to terminally ill patients in Canada often takes many years; And whereas patients who have a terminal illness do not have the luxury of waiting until a life-saving treatment receives final approval for its use; And whereas patients who have a terminal illness have a fundamental right to attempt to pursue the preservation of their own lives by accessing all available potential life-saving treatments; And whereas the use of a potential life-saving treatment is a decision that should be made by the patient with a terminal illness in consultation with the patient s physician; Now, therefore, Her Majesty, by and with the advice and consent of the Senate and House of Commons of Canada, enacts as follows: Title 1. This Act shall be known as the Right to Try Act. Definitions 2. In this Act: a. approving physician means a licensed physician, certified as a specialist by the Royal College of Physicians and Surgeons of Canada, whose practice includes the treatment and care of the eligible patient s terminal illness; b. eligible patient means a person who meets all of the following: i. has a terminal illness; ii. has considered all other treatment options currently approved by Health Canada; iii. has received a prescription or recommendation from an approving physician for a potential life-saving treatment; iv. has given informed consent by any means appropriate to their condition or, if the patient is a minor or lacks the mental capacity to provide informed consent, a parent or legal guardian has given informed consent on the patient's behalf in accordance with any laws of the respective jurisdictions governing substitute decisions; and

2 v. has documentation from a physician that the person has met the requirements of this subsection; c. informed consent is given when an eligible patient confirms their understanding of all of the following: i. a general explanation of the currently approved products and treatments, if any, for the terminal illness from which the eligible patient suffers; ii. a description of the specific proposed potential life-saving treatment that the eligible patient is seeking to use; iii. a general description of the best and worst potential outcomes of using the potential lifesaving treatment and any known risks and side-effects associated with such treatment. If applicable, the description shall include the possibility that new, unanticipated, different, or worse symptoms may result and that death could be hastened by the administration of the proposed potential life-saving treatment; iv. any costs for which the eligible patient may be responsible. d. person includes a corporation; e. potential life-saving treatment means a drug, biological product, device or process, or any combination of the foregoing, which, in the reasonable professional opinion of an approving physician in their absolute discretion, has the potential or possibility, whether or not remote, to: i. treat or cure an eligible patient's terminal illness or assist in the alleviation of the symptoms associated with the terminal illness; ii. extend or prolong an eligible patient s life; iii. stop, delay or reverse the progression of the terminal illness and its symptoms; iv. improve an eligible patient s quality of life; or v. advance the research in the treatment of, or the alleviation of the symptoms associated with, the terminal illness; f. provider of a potential life-saving treatment means: i. a research facility, hospital or other medical institution engaged in investigating a treatment or cure of a terminal illness;

3 ii. iii. a person who manufactures, imports or distributes a drug, biological product, or device which could be used in the treatment of a terminal illness; or any; A. physician, nurse, pharmacist or other regulated health provider; or B. other person as prescribed by the regulations who is involved, either directly or indirectly, in the administration, dispensing, prescribing or delivery of the potential life-saving treatment; and g. terminal illness means an irremediable and incurable disease for which there is no life-saving treatment. For greater certainty, the natural death of a patient suffering from a terminal illness must be reasonably foreseeable. Provision of Potential Life-Saving Treatment 3. A provider of a potential life-saving treatment may make available or administer a potential lifesaving treatment to eligible patients under this Act. This Act does not require that a provider of a potential life-saving treatment make available its potential life-saving treatment to an eligible patient. 4. A provider of a potential life-saving treatment shall have the discretion to devise the conditions, processes and parameters of the administration and delivery of the potential life-saving treatment to an eligible patient. Such conditions, processes and parameters shall include, but not be limited to, the determination of the proper dosing and method of delivery of the potential life-saving treatment, the performance of any necessary tests or examinations and the proper monitoring of the eligible patient s health. A provider of a potential life-saving treatment may administer and deliver a potential lifesaving treatment to one or more eligible patients, in accordance with this Act, in the form of an experimental trial to evaluate the safety, tolerability, efficacy and therapeutic benefit of a potential life-saving treatment. 5. A provider of a potential life-saving treatment may: a. provide a potential life-saving treatment to an eligible patient without receiving compensation; or b. require an eligible patient to pay the costs of or associated with the manufacture, administration or delivery of the potential life-saving treatment. This section does not require a health care insurer to provide coverage for the cost of any potential life-saving treatment. A health care insurer may provide coverage for a potential life-saving treatment. No Liability

4 [ntd - provinces may have to amend legislation regulating the practice of medicine to ensure that professional licences won t be revoked when acting in accordance with this Law] 6. Except in the case of gross negligence or willful misconduct, any provider of a potential-life saving treatment to an eligible patient with a terminal illness in accordance with this Act shall not be: a. liable in any civil action; or b. held criminally responsible pursuant to any law or regulation for any loss, damage, injury or death arising out of, relating to, or resulting from advice given or recommendations made to an eligible patient, the design, development, clinical testing and investigation, manufacturing, labeling, distribution, sale, purchase, donation, dispensing, prescription, administration or use of the potential life-saving treatment or for the safety or effectiveness thereof. [ntd - provinces may have to amend legislation regulating the practice of medicine to address exemption from malpractice claims and provincial offences when acting in accordance with this Law] Filing of Information 7. A provider of a potential life-saving treatment must, in accordance with the regulations, provide the information described in section 4 respecting the administration, delivery and use of a potential lifesaving treatment, together with such other information required by those regulations, to the recipient designated in those regulations. Approval for General Use 8. A potential life-saving treatment of a terminal illness may be approved for general use in Canada, subject to and in accordance with any conditions prescribed by the regulations. Conflict 9. In the event of a conflict between this Act and any other law enacted by the Parliament of Canada, including, but not limited to, the Food and Drug Act, R.S. c. F-27, the Canada Health Act, 1984 c. 6 and the Criminal Code, R.S. C-34, the provisions of this Act shall prevail. Regulations 10. The Minister of Health must make regulations: a. prescribing additional persons as providers of potential life-saving treatment for the purposes of subparagraph 2(d)(iii)(B) and the conditions under which they may provide treatment; and

5 b. respecting the filing of information by a provider of a potential life-saving treatment pursuant to section 7; and c. prescribing the conditions under which a potential life-saving treatment may be approved for general use in Canada pursuant to section 8. Offence and Punishment 11. Any provider of a potential life-saving treatment who knowingly fails to comply with this Act or the regulations, a. is guilty of an indictable offence and liable to a term of imprisonment of not more than two years; b. is guilty of an offence punishable on summary conviction; or c. is liable to pay a fine which shall not exceed * * * dollars ($* * *). [ntd - to determine amount of fine]